Home › Funds › Rubric Capital Management LP › SUPN

Rubric Capital Management LP position in SUPN

SUPERNUS PHARMACEUTICALS · Health Care

Rubric Capital Management LP reported holding 1,739,892 shares of SUPN (SUPERNUS PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$74.9M, representing 0.71% of its reported portfolio and ranking #43 among its reported holdings. Rubric Capital Management LP has disclosed SUPN holdings in 3 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)1.74M sh
Reported value held$74.88M
Portfolio Weight0.71%
First reportedQ2 2025
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Rubric Capital Management LP's SUPN position evolved

Rubric Capital Management LP first disclosed a stake in SUPN in Q2 2025 at 695,039 shares (US$21.9M). The position peaked in Q3 2026 at 1,739,892 shares, worth US$74.9M. Across 3 filings, Rubric Capital Management LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,739,892 shares valued at US$74.9M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 695.04K $21.91M New
Q3 2025 595.37K $28.45M Reduce
Q3 2026 1.74M $74.88M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SUPN and 13F data

SUPN (SUPERNUS PHARMACEUTICALS) is a Health Care company. 30 other funds we track also report a position in SUPN — the largest reported positions include ARMISTICE CAPITAL, LLC (US$109.7M), SYSTEMATIC FINANCIAL MANAGEMENT LP (US$34.6M), ASHFORD CAPITAL MANAGEMENT INC (US$26.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SUPN

All SUPN fund holders →

FAQ

How long has Rubric Capital Management LP held SUPN?

Rubric Capital Management LP has disclosed SUPN holdings in 3 of the last 6 reported quarters, going back to Q2 2025.

What is Rubric Capital Management LP's current position in SUPN?

As of Q3 2026, Rubric Capital Management LP holds 1.74M shares of SUPN (SUPERNUS PHARMACEUTICALS), valued at $74.88M, representing 0.71% of its reported portfolio and ranking #43.

Has Rubric Capital Management LP been buying or selling SUPN?

In the latest 13F filing (Q3 2026), Rubric Capital Management LP newly opened its position in SUPN. The position peaked in Q3 2026 at 1.74M shares.

Which other funds hold SUPN?

Other major institutional holders of SUPN include ARMISTICE CAPITAL, LLC, SYSTEMATIC FINANCIAL MANAGEMENT LP, ASHFORD CAPITAL MANAGEMENT INC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.